Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Natren is a pioneer in the probiotic industry, specializing in the development and manufacturing of high-potency beneficial bacteria supplements. Founded in 1982 by Natasha Trenev, the company is recognized for establishing rigorous quality standards in the probiotic market, including the use of pharmaceutical-grade manufacturing processes. Their product portfolio features specialized strains of Lactobacillus acidophilus, Bifidobacterium bifidum, and Lactobacillus bulgaricus, often delivered via their proprietary Trenev Process oil-matrix system. Natren's products are designed to support gastrointestinal health, immune function, and vaginal flora balance. The company operates its own manufacturing facility in California to ensure complete control over the culturing and packaging of its live microorganisms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Natren.